Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (104) 104
humans (97) 97
brain neoplasms - genetics (80) 80
clinical neurology (71) 71
gliomas (71) 71
oncology (66) 66
tumors (65) 65
male (57) 57
oligodendroglioma (56) 56
female (55) 55
glioma (55) 55
adult (52) 52
1p/19q (50) 50
1p/19q co-deletion (49) 49
middle aged (48) 48
mutation (47) 47
prognosis (46) 46
brain neoplasms - pathology (45) 45
medicine & public health (45) 45
survival (43) 43
classification (42) 42
oligodendroglioma - genetics (41) 41
isocitrate dehydrogenase - genetics (39) 39
chromosomes, human, pair 1 - genetics (38) 38
pathology (38) 38
glioblastoma (37) 37
chromosome deletion (36) 36
chemotherapy (35) 35
19q (32) 32
aged (32) 32
cancer (32) 32
glioma - genetics (32) 32
chromosomes, human, pair 19 - genetics (31) 31
analysis (29) 29
neurosciences (29) 29
brain cancer (28) 28
neurology (28) 28
brain neoplasms - diagnosis (27) 27
brain tumors (26) 26
temozolomide (26) 26
phase-iii trial (24) 24
oligodendroglioma - pathology (23) 23
young adult (22) 22
anaplastic oligodendroglioma (21) 21
diagnosis (21) 21
idh (21) 21
retrospective studies (21) 21
surgery (21) 21
astrocytoma (20) 20
idh1 (20) 20
genetic aspects (19) 19
radiotherapy (19) 19
19q co-deletion (18) 18
1p/19q loss (18) 18
atrx (18) 18
brain neoplasms - therapy (18) 18
central-nervous-system (18) 18
gene deletion (18) 18
glioma - pathology (18) 18
idh2 mutations (18) 18
idh mutation (16) 16
mgmt (16) 16
mutations (16) 16
neoplasm grading (16) 16
oligodendroglioma - diagnosis (16) 16
tumor proteins (16) 16
adolescent (15) 15
biomarkers, tumor - genetics (15) 15
glioma - diagnosis (15) 15
immunohistochemistry (15) 15
isocitrate dehydrogenase (15) 15
low-grade gliomas (15) 15
mutation - genetics (15) 15
astrocytomas (14) 14
brain neoplasms - classification (14) 14
chromosomes, human, pair 1 (14) 14
european organization (14) 14
magnetic resonance imaging (14) 14
neurosurgery (14) 14
1p/19q codeletion (13) 13
adjuvant procarbazine (13) 13
brain neoplasms - metabolism (13) 13
chromosomes, human, pair 19 (13) 13
clonal deletion (13) 13
glioma - classification (13) 13
patients (13) 13
1p/19q deletion (12) 12
brain neoplasms - mortality (12) 12
deletion (12) 12
gene expression (12) 12
glioblastoma - genetics (12) 12
glioblastoma-multiforme (12) 12
methylation (12) 12
mgmt promoter methylation (12) 12
radiation-therapy (12) 12
radiology, nuclear medicine & medical imaging (12) 12
chromosomes (11) 11
dna methylation (11) 11
medical colleges (11) 11
molecular classification (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
by Hu, Xin and Martinez-Ledesma, Emmanuel and Zheng, Siyuan and Kim, Hoon and Barthel, Floris and Jiang, Tao and Hess, Kenneth R and Verhaak, Roel G.W
Neuro-Oncology, ISSN 1522-8517, 2017, Volume 19, Issue 6, pp. 786 - 795
Background. Co-deletion of 1p and 19q marks a diffuse glioma subtype associated with relatively favorable overall survival; however, heterogeneous clinical... 
Prognostic factor | Glioma | 1p/19q co-deletion | elastic net Cox regression model | SURVIVAL | 1P/19Q | prognostic factor | MICROARRAY | GENOMIC ANALYSIS | PROCARBAZINE | CLINICAL NEUROLOGY | MOLECULAR CLASSIFICATION | ONCOLOGY | RNA-SEQ | VINCRISTINE | GENE-EXPRESSION | glioma | PROGRESSION | Prognosis | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | Transcriptome | Male | Glioma - genetics | Young Adult | Chromosomes, Human, Pair 1 | Glioma - pathology | Glioma - therapy | Aged, 80 and over | Adult | Female | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Survival Rate | Chromosomes, Human, Pair 19 | Adolescent | Brain Neoplasms - therapy | Chromosome Aberrations | Aged | Biomarkers, Tumor - genetics | Mutation | 19q co-deletion | Basic and Translational Investigations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution
by Boots-Sprenger, Sana H. E and Sijben, Angelique and Rijntjes, Jos and Tops, Bastiaan B. J and Idema, Albert J and Rivera, Aneana L and Bleeker, Fonnet E and Gijtenbeek, Anja M and Diefes, Kristin and Heathcock, Lindsey and Aldape, Kenneth D and Jeuken, Judith W. M and Wesseling, Pieter
Modern pathology, ISSN 0893-3952, 2013, Volume 26, Issue 7, pp. 922 - 929
The histopathological diagnosis of diffuse gliomas often lacks the precision that is needed for tailored treatment of individual patients. Assessment of the... 
glioma | complete 1p/19q co-deletion | MGMT | molecular markers | IDH1 | SURVIVAL | DEPENDENT PROBE AMPLIFICATION | NUMBER CHANGES | PROGNOSIS | NEWLY-DIAGNOSED GLIOBLASTOMA | MARKERS | CLASSIFICATION | PATHOLOGY | GRADE GLIOMAS | GENETIC ALTERATIONS | Prognosis | Glioma - classification | Humans | Middle Aged | DNA Repair Enzymes - genetics | Male | Glioma - genetics | Chromosomes, Human, Pair 19 - genetics | DNA Methylation | Gene Deletion | Tumor Suppressor Proteins - genetics | Adult | Female | Brain Neoplasms - mortality | Chromosomes, Human, Pair 1 - genetics | Chromosome Deletion | Promoter Regions, Genetic | Glioma - mortality | Kaplan-Meier Estimate | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | DNA Modification Methylases - genetics | Brain Neoplasms - classification | Biomarkers, Tumor - genetics | Mutation | Pathology, Molecular | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion
by Kawaguchi, Tomohiro and Sonoda, Yukihiko and Shibahara, Ichiyo and Saito, Ryuta and Kanamori, Masayuki and Kumabe, Toshihiro and Tominaga, Teiji
Journal of Neuro-Oncology, ISSN 0167-594X, 09/2016, Volume 129, Issue 3, pp. 505 - 514
The prognosis of patients with WHO grade III gliomas is highly dependent on their genomic status such as the isocitrate dehydrogenase (IDH) 1/2 mutation... 
WHO grade III | 1p/19q | Glioma | Magnetic resonance imaging | IDH | Surgery | SURVIVAL | ANAPLASTIC OLIGODENDROGLIOMAS | GLIOBLASTOMA-MULTIFORME | EUROPEAN ORGANIZATION | CONTRAST ENHANCEMENT | CLINICAL NEUROLOGY | RADIATION-THERAPY | BRAIN-TUMORS | TRIAL | AMPLIFICATION | ONCOLOGY | 2-HYDROXYGLUTARATE | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | DNA Repair Enzymes - genetics | Male | Brain Neoplasms - surgery | Glioma - genetics | Young Adult | Chromosomes, Human, Pair 19 - genetics | Tumor Suppressor Proteins - genetics | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Chromosomes, Human, Pair 1 - genetics | Glioma - surgery | Chromosome Deletion | Glioma - mortality | Tomography Scanners, X-Ray Computed | Kaplan-Meier Estimate | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Mutation - genetics | Magnetic Resonance Imaging | DNA Modification Methylases - genetics | Glioma - diagnostic imaging | Aged | Genetic research | Medical colleges | Care and treatment | Genetic aspects | Gliomas
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text F-18-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma
by Cicone, F and Carideo, L and Scaringi, C and Arcella, A and Giangaspero, F and Scopinaro, F and Minniti, G
ANNALS OF NUCLEAR MEDICINE, ISSN 0914-7187, 04/2019, Volume 33, Issue 4, pp. 295 - 302
Objective The role of amino acid positron emission tomography (PET) in glioma grading and outcome prognostication has not yet been well established. This is... 
Amino acid PET | Glioma | 1p/19q co-deletion | WHO 2016 | AMINO-ACID PET | IDH mutation | CLASSIFICATION | DOPA | PROGNOSTIC VALUE | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PREDICTION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas
by Han, Yuqi and Xie, Zhen and Zang, Yali and Zhang, Shuaitong and Gu, Dongsheng and Zhou, Mu and Gevaert, Olivier and Wei, Jingwei and Li, Chao and Chen, Hongyan and Du, Jiang and Liu, Zhenyu and Dong, Di and Tian, Jie and Zhou, Dabiao
Journal of Neuro-Oncology, ISSN 0167-594X, 11/2018, Volume 140, Issue 2, pp. 297 - 306
To perform radiomics analysis for non-invasively predicting chromosome 1p/19q co-deletion in World Health Organization grade II and III (lower-grade)... 
Neurology | Lower-grade glioma | Medicine & Public Health | Magnetic resonance imaging | Prediction | Oncology | 1p/19q Co-deletion | Radiomics | SURVIVAL | MANAGEMENT | GLIOBLASTOMA-MULTIFORME | CLASSIFICATION | 19Q | OLIGODENDROGLIAL TUMORS | CLINICAL NEUROLOGY | TEMOZOLOMIDE | IMPACT | ONCOLOGY | 19q Co-deletion | RADIOTHERAPY | Chromosome Deletion | Area Under Curve | Brain Neoplasms - diagnostic imaging | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Brain Neoplasms - pathology | Brain Neoplasms - genetics | In Situ Hybridization, Fluorescence | Male | Glioma - genetics | Young Adult | Magnetic Resonance Imaging | Chromosomes, Human, Pair 19 | Chromosomes, Human, Pair 1 | Glioma - diagnostic imaging | Neoplasm Grading | Glioma - pathology | Adolescent | Adult | Female | ROC Curve | Aged | Retrospective Studies | Medical research | Algorithms | Gliomas | Genetic research | Medicine, Experimental | Genetic aspects | Glioma | Clonal deletion | Chromosome deletion | Gene deletion | Genotypes | Chromosome 1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text 18 F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma
by Cicone, Francesco and Carideo, Luciano and Scaringi, Claudia and Arcella, Antonietta and Giangaspero, Felice and Scopinaro, Francesco and Minniti, Giuseppe
Annals of Nuclear Medicine, ISSN 0914-7187, 04/2019, Volume 33, Issue 4, pp. 295 - 302
The role of amino acid positron emission tomography (PET) in glioma grading and outcome prognostication has not yet been well established. This is particularly... 
IDH mutation | Amino acid PET | Glioma | DOPA | 1p/19q co-deletion | WHO 2016 | Chromosome Deletion | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Dihydroxyphenylalanine - analogs & derivatives | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Male | Brain Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Positron Emission Tomography Computed Tomography | Chromosomes, Human, Pair 19 - genetics | Dihydroxyphenylalanine - metabolism | Glioma - diagnostic imaging | Biological Transport | Survival Analysis | Female | Chromosomes, Human, Pair 1 - genetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Co-deletion of 1p/19q as Prognostic and Predictive Biomarker for Patients in West Bohemia with Anaplastic Oligodendroglioma
by Polivka, Jiri and Polivka, Jiri and Repik, Tomas and Rohan, Vladimir and Hes, Ondrej and Topolcan, Ondrej
Anticancer research, ISSN 0250-7005, 01/2016, Volume 36, Issue 1, pp. 471 - 476
Background: Anaplastic oligodendrogliomas (AO) are rare tumors. Two phase III clinical trials (RTOG 9402 and EORTC 26951) proved favorable effects of... 
prognostic biomarker | predictive biomarker | 1p/19q co-deletion | anaplastic oligodendroglioma | GLIOMAS | GLIOBLASTOMA-MULTIFORME | LOMUSTINE | TUMORS | CHEMOTHERAPY | PHASE-III TRIAL | ADJUVANT PROCARBAZINE | ONCOLOGY | CODON 132 MUTATION | TREATMENT PARADIGM | BRAIN | Biomarkers - metabolism | Chromosome Deletion | Prognosis | Chromosomes, Human, Pair 1 - metabolism | Humans | Male | Brain Neoplasms - drug therapy | Chromosomes, Human, Pair 19 - genetics | Czech Republic | Female | Chromosomes, Human, Pair 1 - genetics | Chromosomes, Human, Pair 19 - metabolism | Oligodendroglioma - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma
by Cicone, Francesco and Carideo, Luciano and Scaringi, Claudia and Arcella, Antonietta and Giangaspero, Felice and Scopinaro, Francesco and Minniti, Giuseppe
Annals of Nuclear Medicine, ISSN 0914-7187, 4/2019, Volume 33, Issue 4, pp. 295 - 302
The role of amino acid positron emission tomography (PET) in glioma grading and outcome prognostication has not yet been well established. This is particularly... 
Medicine & Public Health | Amino acid PET | Glioma | 1p/19q co-deletion | WHO 2016 | IDH mutation | Nuclear Medicine | Imaging / Radiology | DOPA | Neuroimaging | Brain | Fingerprints | Brain tumors | Amino acids | Population studies | Gene deletion | Subgroups | Regression models | Clonal deletion | Computed tomography | Neostriatum | Tomography | Deletion | Dihydroxyphenylalanine | Evaluation | Parameters | Phenylalanine | Positron emission | Fluorine isotopes | Regression analysis | Radiation therapy | Patients | Survival | Correlation analysis | Medical prognosis | Mutation | Dopa | Positron emission tomography | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma
by Lei, Lei and Jiang, Zhiming and Zhang, Gu and Cheng, Qiaoyuan and Lu, Hongyang
World Journal of Surgical Oncology, ISSN 1477-7819, 06/2018, Volume 16, Issue 1, pp. 110 - 6
Background: The response to temozolomide (TMZ) treatment in small-cell lung cancer (SCLC) correlated with O(6)-methylguanine-DNA methyltransferase (MGMT)... 
Pulmonary carcinoid | MGMT methylation | Large-cell neuroendocrine carcinoma | 1p/19q co-deletion | SURGERY | MANAGEMENT | RARE | CLASSIFICATION | COMBINATION | TUMORS | CHEMOTHERAPY | TEMOZOLOMIDE | LUNG-CANCER | ONCOLOGY | DNA METHYLTRANSFERASE | EXPERIENCE | Carcinoid Tumor - surgery | Prognosis | Humans | Middle Aged | DNA Repair Enzymes - genetics | Male | Promoter Regions, Genetic - genetics | Chromosomes, Human, Pair 19 - genetics | China | Tumor Suppressor Proteins - genetics | Adult | Female | Carcinoma, Large Cell - genetics | Retrospective Studies | Chromosomes, Human, Pair 1 - genetics | Chromosome Deletion | Lung Neoplasms - genetics | Carcinoma, Neuroendocrine - genetics | Carcinoma, Neuroendocrine - surgery | DNA Methylation - genetics | Disease-Free Survival | DNA Modification Methylases - genetics | Carcinoid Tumor - genetics | Carcinoma, Large Cell - surgery | Lung Neoplasms - surgery | Aged | Cancer patients | Methylation | Health aspects | Analysis | Brain cancer | Lung cancer | Fluorescence | Vertebra | Metastasis | Gene deletion | Cancer therapies | Metastases | O6-methylguanine-DNA methyltransferase | Clonal deletion | Surgery | Fluorescence in situ hybridization | DNA methylation | Deletion | Age | Deoxyribonucleic acid--DNA | Small cell lung carcinoma | Methylguanine | Radiation therapy | Patients | Oligodendroglioma | Chemotherapy | Hospitals | Medical prognosis | Biomarkers | DNA methyltransferase | Fatalities | Mutation | Temozolomide | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients
by Wang, Kai and Wang, Kai and Wang, Yinyan and Wang, Yinyan and Fan, Xing and Fan, Xing and Li, Yanong and Li, Yanong and Liu, Xing and Liu, Xing and Wang, Jiangfei and Wang, Jiangfei and Ai, Lin and Ai, Lin and Dai, Jianping and Dai, Jianping and Jiang, Tao and Jiang, Tao
Journal of Neuro-Oncology, ISSN 0167-594X, 2/2018, Volume 136, Issue 3, pp. 523 - 531
In this study we aimed to identify the anatomic features of 1p/19q co-deletion and investigate the predictive values of tumor location and radiological... 
Neurology | Oligodendroglial | Medicine & Public Health | 1p/19q | Survival outcome | Radiology | Oncology | Anaplastic | GLIOMAS | LOCATION | GENETIC SIGNATURE | CLINICAL NEUROLOGY | TEMOZOLOMIDE | GRADE II | GLIOBLASTOMA | SPECTROSCOPY | ONCOLOGY | GROWTH | ENHANCEMENT | EPIDEMIOLOGY | Chromosome Deletion | Oligodendroglioma - mortality | Brain - diagnostic imaging | Prognosis | Follow-Up Studies | Oligodendroglioma - genetics | Brain Neoplasms - diagnosis | Humans | Middle Aged | Oligodendroglioma - diagnosis | Brain Neoplasms - genetics | In Situ Hybridization, Fluorescence | Male | Young Adult | Magnetic Resonance Imaging | Chromosomes, Human, Pair 19 | Chromosomes, Human, Pair 1 | Adolescent | Adult | Female | Aged | Retrospective Studies | Brain Neoplasms - mortality | Gliomas | Patient outcomes | Analysis | Brain tumors | Edema | Frontal lobe | Brain cancer | Brain mapping | Data processing | Genomes | Survival | Survival analysis | Glioma | Clonal deletion | Gene mapping | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion
by Gladitz, J and Klink, B and Seifert, M
ACTA NEUROPATHOLOGICA COMMUNICATIONS, ISSN 2051-5960, 06/2018, Volume 6, Issue 1, pp. 49 - 15
Oligodendrogliomas are primary human brain tumors with a characteristic 1p/19q co-deletion of important prognostic relevance, but little is known about the... 
Network biology | Network inference | GLIOMA | Network propagation | Computational systems biology | CELL-PROLIFERATION | NEUROSCIENCES | Cancer genomics | BREAST-CANCER | INVASION | 1p/19q co-deletion | ZINC-FINGER PROTEIN | TUMOR-SUPPRESSOR | CENTRAL-NERVOUS-SYSTEM | HYPERMETHYLATOR PHENOTYPE | MUTATIONS | Bioinformatics | GLIOBLASTOMA CELLS | Oligodendrogliomas | Chromosome Deletion | Oligodendroglioma - genetics | Humans | Computational Biology | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Male | Gene Dosage | Signal Transduction - genetics | Mutation - genetics | Neoplasm Proteins - metabolism | Vesicular Glutamate Transport Protein 1 - genetics | Chromosomes, Human, Pair 19 - genetics | Metabolic Networks and Pathways - genetics | Succinate Dehydrogenase - genetics | Female | Chromosomes, Human, Pair 1 - genetics | Neoplasm Proteins - genetics | Gene Expression Regulation, Neoplastic - genetics | Epigenetic inheritance | Gene mutations | Gliomas | Analysis | Genes | Brain tumors | Genetic research | Kallikrein | Development and progression | Genetic aspects | Gene expression | Cancer | Proteins | Propagation | Brain cancer | Genomes | Mutation | Metabolism | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Comprehensive analysis of genes based on chr1p/ 19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma
by Zhang, Chuang and Yu, Ruoxi and Li, Zhi and Song, Huicong and Zang, Dan and Deng, Mingming and Fan, Yibo and Liu, Yunpeng and Zhang, Ye and Qu, Xiujuan
Cancer Management and Research, ISSN 1179-1322, 2019, Volume 11, pp. 4971 - 4984
The chr1p/19q co-deletion is a favorable prognostic factor in patients with lower grade glioma. The aim of this study was to reveal key genes for prognosis and... 
Prognostic signature | Lower grade glioma | 1p/19q co-deletion | Rbsurv | rbsurv | prognostic signature
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Molecular characteristics of glioblastoma with 1p/19q co-deletion
by Mizoguchi, Masahiro and Yoshimoto, Koji and Ma, Xinlong and Guan, Yanlei and Hata, Nobuhiro and Amano, Toshiyuki and Nakamizo, Akira and Suzuki, Satoshi O and Iwaki, Toru and Sasaki, Tomio
Brain Tumor Pathology, ISSN 1433-7398, 7/2012, Volume 29, Issue 3, pp. 148 - 153
Recent developments in molecular analysis have revealed genetic alterations in human gliomas. Loss of heterozygosity (LOH) is a critical molecular marker for... 
Pathology | Medicine & Public Health | Diagnostic Radiology | 1p/19q co-deletion | IDH1/2 | Glioblastoma | Oncology | Neurosurgery | OLIG2 | Surgical Oncology | Neuroradiology | Oligodendroglioma | Olig2 | GLIOMAS | SURVIVAL | co-deletion | ANAPLASTIC OLIGODENDROGLIOMAS | 1p/19q | PROGNOSIS | IDH1 | 19Q | PATHOLOGY | CLINICAL NEUROLOGY | BRAIN-TUMORS | PHASE-III TRIAL | ONCOLOGY | GRADE | Receptor, Epidermal Growth Factor - genetics | Basic Helix-Loop-Helix Transcription Factors - genetics | Humans | Transcriptome | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Oligodendrocyte Transcription Factor 2 | Loss of Heterozygosity | Nerve Tissue Proteins - genetics | Chromosomes, Human, Pair 19 - genetics | Glioblastoma - genetics | Gene Deletion | Chromosomes, Human, Pair 1 - genetics | Real-Time Polymerase Chain Reaction | oligodendroglioma | Epidermal growth factor receptors | Brain tumors | Olig2 protein | Gene deletion | Gene expression | Reviews | Glioma | chromosome 10 | Classification | Loss of heterozygosity | Point mutation | Isocitrate dehydrogenase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Role of chromosomal 1p/19q co-deletion on the prognosis of oligodendrogliomas: A systematic review and meta-analysis
by Hu, Nan and Richards, Rachel and Jensen, Randy
Interdisciplinary Neurosurgery, ISSN 2214-7519, 2016, Volume 5, Issue C, pp. 58 - 63
Abstract Background The impact of chromosomal 1p/19q co-deletion on the prognosis of oligodendrogliomas has been measured in many studies previously. However... 
Medical Education | Neurosurgery | Overall survival | Chromosomal 1p/19q co-deletion | Hazard ratio | Standardized mean difference | Progression free survival | Oligodendroglioma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Identification of time-to-peak on dynamic 18 F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma
by Suchorska, Bogdana and Giese, Armin and Biczok, Annamaria and Unterrainer, Marcus and Weller, Michael and Drexler, Mark and Bartenstein, Peter and Schüller, Ulrich and Tonn, Jörg-Christian and Albert, Nathalie L
Neuro-Oncology, ISSN 1522-8517, 01/2018, Volume 20, Issue 2, pp. 279 - 288
glioma | IDH1/2 mutation | prognostic value | 1p/19q co-deletion | kinetic analysis | 18 F-FET-PET
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text ATRX immunohistochemistry can help refine 'not elsewhere classified' categorisation for grade II/III gliomas
by Burford, C and Laxton, R and Sidhu, Z and Aizpurua, M and King, A and Bodi, I and Ashkan, K and Al-Sarraj, S
British Journal of Neurosurgery, ISSN 0268-8697, 09/2019, Volume 33, Issue 5, pp. 536 - 540
Purpose: The 2016 WHO tumour classification highlights the role of IDH1/2 gene mutation and 1p/19q co-deletion in classifying grade II/III gliomas. A recent... 
grade II/III glioma | 1p/19q co-deletion | ATRX
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Static and dynamic F-18-FET PET for the characterization of gliomas defined by IDH and 1p/19q status
by Verger, A and Stoffels, G and Bauer, EK and Lohmann, P and Blau, T and Fink, GR and Neumaier, B and Shah, NJ and Langen, KJ and Galldiks, N
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 03/2018, Volume 45, Issue 3, pp. 443 - 451
Purpose The molecular features isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion have gained major importance for both glioma typing and prognosis... 
SURVIVAL | MRI | RESPONSE ASSESSMENT | IDH mutation | CLASSIFICATION | PROGNOSTIC VALUE | TUMORS | PROCARBAZINE | O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET | GRADE II | Glioma | 1p/19q co-deletion | FET pet | VINCRISTINE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Details down arrow
18. Full Text Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
by Weller, Michael and Weber, Ruthild G and Willscher, Edith and Riehmer, Vera and Hentschel, Bettina and Kreuz, Markus and Felsberg, Jörg and Beyer, Ulrike and Löffler-Wirth, Henry and Kaulich, Kerstin and Steinbach, Joachim P and Hartmann, Christian and Gramatzki, Dorothee and Schramm, Johannes and Westphal, Manfred and Schackert, Gabriele and Simon, Matthias and Martens, Tobias and Boström, Jan and Hagel, Christian and Sabel, Michael and Krex, Dietmar and Tonn, Jörg C and Wick, Wolfgang and Noell, Susan and Schlegel, Uwe and Radlwimmer, Bernhard and Pietsch, Torsten and Loeffler, Markus and von Deimling, Andreas and Binder, Hans and Reifenberger, Guido
Acta Neuropathologica, ISSN 0001-6322, 5/2015, Volume 129, Issue 5, pp. 679 - 693
Cerebral gliomas of World Health Organization (WHO) grade II and III represent a major challenge in terms of histological classification and clinical... 
Pathology | Neurosciences | Medicine & Public Health | 1p/19q co-deletion | Gene expression profiles | Array-based comparative genomic hybridization | Isocitrate dehydrogenase | Astrocytoma | Integrative bioinformatics | Oligodendroglioma | MGMT PROMOTER METHYLATION | ASTROCYTIC TUMORS | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | FREQUENT ATRX | PHASE-III TRIAL | ADJUVANT PROCARBAZINE | GLIOBLASTOMA | ANAPLASTIC OLIGODENDROGLIOMA | GENE-EXPRESSION | MALIGNANT GLIOMAS | IDH1 MUTATION | Promoter Regions, Genetic | Sequence Deletion | Prognosis | World Health Organization | Glioma - classification | Neoplasm Grading - methods | Humans | Middle Aged | Brain Neoplasms - genetics | Gene Expression Profiling - methods | Isocitrate Dehydrogenase - genetics | Male | Glioma - genetics | Young Adult | Glioma - pathology | Aged, 80 and over | Adult | Female | Aged | Glioma - physiopathology | Mutation | Genomics - methods | Gliomas | Analysis | Genomics | Genomes | Genetic aspects | Gene expression | Telomerase | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights